The Weight Loss Showdown: Semaglutide vs
In clinical trials, participants reported an average weight loss of approximately 15% of their body weight over a 72-week period
Footnotes European Medicines Agency, Wegovy (semaglutide) EPAR Product Information, sections 4.2, 4.4 and 4.8
DOI: 10.1016/j.obpill.2024.100143, Written by Priyanjana Pramanik Priyanjana Pramanik is a writer based in Kolkata, India, with an academic background in Wildlife Biology and economics
Either way, it has proven effective in lowering blood sugar for people with Type 2 diabetes
While diet and exercise are important, theyre not the whole story